US 7994306
Methods of treating cancer using siRNA molecules directed against CD24
granted A61PA61P35/00A61P37/00
Quick answer
US patent 7994306 (Methods of treating cancer using siRNA molecules directed against CD24) held by The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center
- Grant date
- Tue Aug 09 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61P, A61P35/00, A61P37/00